Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 19:2022:9831012.
doi: 10.34133/2022/9831012. eCollection 2022.

Nanozyme-Triggered Cascade Reactions from Cup-Shaped Nanomotors Promote Active Cellular Targeting

Affiliations

Nanozyme-Triggered Cascade Reactions from Cup-Shaped Nanomotors Promote Active Cellular Targeting

Xin Wang et al. Research (Wash D C). .

Abstract

Self-propelled nanomotors have shown enormous potential in biomedical applications. Herein, we report on a nanozyme-powered cup-shaped nanomotor for active cellular targeting and synergistic photodynamic/thermal therapy under near-infrared (NIR) laser irradiation. The nanomotor is constructed by the asymmetric decoration of platinum nanoparticles (PtNPs) at the bottom of gold nanocups (GNCs). PtNPs with robust peroxidase- (POD-) like activity are employed not only as propelling elements for nanomotors but also as continuous O2 generators to promote photodynamic therapy via catalyzing endogenous H2O2 decomposition. Owing to the Janus structure, asymmetric propulsion force is generated to trigger the short-ranged directional diffusion, facilitating broader diffusion areas and more efficient cellular searching and uptake. This cascade strategy combines key capabilities, i.e., endogenous substrate-based self-propulsion, active cellular targeting, and enhanced dual-modal therapy, in one multifunctional nanomotor, which is crucial in advancing self-propelled nanomotors towards eventual therapeutic agents.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
Schematic illustration of the nanozyme-powered GNCs-Pt-ICG/Tf nanomotor for enhanced dual-modal phototherapy upon NIR laser irradiation via a cascaded strategy consisting of the catalytic and photodynamic reactions.
Figure 2
Figure 2
The preparation and characterization of GNCs-Pt. (a) Schematic representation of the preparation of GNCs-Pt. (b) UV-vis spectra of GNCs (red) and GNCs-Pt (green). Dark-field optical microscopic (c), SEM (d), and TEM (e) images of GNCs-Pt. (f) HAADF-STEM images and corresponding elemental maps of GNCs-Pt. (g) Size distribution of GNCs (red, 149 ± 16 nm) and GNCs-Pt (green, 154 ± 11 nm) determined by SEM images (based on 150 particles). Data are represented as mean ± SD. (h) Single-particle scattering spectra of GNCs (red) and GNCs-Pt (green). The gray line is the fitted curve based on Gaussian function. (i) The polarization-dependent scattering response (green circles) from a single GNC-Pt as a function of the angle relative to the optical axis of the polarizer. (j) Zeta potential of hexadecyl trimethyl ammonium bromide (CTAB) stabilized PbS NPs (blue, 48.9 ± 1.1 mV), GNCs (red, 35.8 ± 0.1 mV), and GNCs-Pt (green, 55.4 ± 0.3 mV). Inset: schematic diagrams of corresponding nanomaterials.
Figure 3
Figure 3
The POD-like activity of GNCs-Pt. (a) Schematic illustration of the POD-like activity of GNCs-Pt with TMB as the substrate. (b) Optical images of the oxTMB produced under different catalytic conditions for 30 min. (I) TMB + H2O2, (II) GNCs - Pt + H2O2 + TMB, (III) GNCs - Pt +TMB, (IV) GNCs + H2O2 + TMB, (V) GNCs + TMB. (c) The TMB oxidation reactions in GNCs or GNCs-Pt solutions with and without H2O2 (1%) in the disodium hydrogen phosphate-citric acid buffer (0.1 M, pH 3.0). [GNCs‐Pt] = 0.27 mg/mL, [GNCs] = 0.27 mg/mL, [TMB] = 1.0 mM. (d) and (e) Effects of the concentrations of GNCs-Pt and H2O2 on the POD-like activity.
Figure 4
Figure 4
Enhanced diffusion of GNCs-Pt in long term with different H2O2 concentrations (0, 1, 2, 3, 5, and 10%). (a) Illustration of the self-electrophoresis of a GNC-Pt via catalyzing the decomposition of H2O2. A gradient of electric charge density will be generated across the GNC-Pt as reaction proceeds. Electroosmotic flow induced by the charge imbalance will then drive GNCs-Pt to move in the direction opposite to that of the fluid flow (red arrow). (b) Trajectories (for 10 s), (c) instantaneous velocity, and (d) EA-TA-MSD of GNCs-Pt at different H2O2 concentrations. (e) Dependence of De of GNCs-Pt with different H2O2 concentrations. (f) The distributions of De of GNCs-Pt with different H2O2 concentrations. The dashed lines are the fitted curve based on Gaussian function.
Figure 5
Figure 5
The temporal heterogeneity of diffusion behaviors of GNCs-Pt in the absence or presence of H2O2 (10%). (a) Trajectories of GNCs-Pt with the color-coded speed during 10 s. The color bar from purple to deep red represents the speed from 0 to 20 μm/s. (b) The distributions of diffusion modes including subdiffusion, Brownian motion (BW), and superdiffusion. (c) The distributions of De of GNCs-Pt by a moving time-window method (1 s).
Figure 6
Figure 6
The ROS generation and photothermal properties of GNCs-Pt-ICG/Tf. (a) Schematic illustration of the mechanism of GNCs-Pt-ICG/Tf for synergistic PDT/PTT upon NIR laser irradiation via a cascade reaction. (b)–(d) The ROS generation ability of GNCs-Pt-ICG/Tf with SOSG as an indicator. (b) GNCs-Pt-ICG/Tf in the presence of H2O2 (1%) with and without 808 nm laser. (c) GNCs-Pt-ICG/Tf in the absence of H2O2 with and without 808 nm laser. (d) GNCs-Pt-ICG/Tf and free ICG in different conditions. [nanomaterials] = 270 μg/mL; [ICG] = 9.05 μM; laser: 808 nm, 2 W/cm2. (e)–(g) Photothermal properties of GNCs-Pt-ICG/Tf and GNCs-ICG/Tf. (e) Temperature evaluation of GNCs-Pt-ICG/Tf, GNCs-ICG/Tf, PBS, and deionized water with 808 nm laser irradiation for different times. (f) A plot of −lnθ versus time obtained from the cooling period for 15 min. (g) The photostability of GNCs-Pt-ICG/Tf and GNCs-ICG/Tf in PBS with 808 nm laser on and off for five cycles. [nanomaterials] = 137 μg/mL; PBS: 10 mM, pH = 7.4; laser: 808 nm, 2 W/cm2.
Figure 7
Figure 7
Cytotoxicity and antitumor efficacy of GNCs-Pt-ICG/Tf in vitro. (a) HepG2 cell viability incubated with GNCs-Pt-ICG/Tf of various concentrations (0, 1, 5, 10, 25, and 50 μg/mL) for 24 h. Error bars represent the mean ± SD (n = 5). (b) The effects of PtNPs and Tf/ICG modification on the cellular uptake efficiency of GNCs-Pt-ICG/Tf. Inset: schematic diagrams of the corresponding nanomaterials. (c) The cellular uptake capability of (i) GNCs-Pt-ICG/Tf, (ii) GNCs-Pt-ICG, (iii) GNCs-ICG/Tf, and (iv) GNCs-ICG for HepG2 cells and (v) GNCs-Pt-ICG/Tf and (vi) GNCs-Pt-ICG for NCTC1469 cells, respectively. Confocal laser scanning microscopy (CLSM) images (d) and corresponding cell mortality (e) of HepG2 cells treated with (I) culture medium, (II) GNCs-Pt-ICG/Tf+laser, (III) GNCs-Pt-ICG/Tf (in dark), (IV) GNCs-Pt-Tf+laser, (V) free ICG+laser, and (VI) GNCs-ICG/Tf+laser, respectively. Scale bar: 50 μm. (f) CLSM images of HepG2 cells cocultured with GNCs-Pt-ICG/Tf at the edge of laser irradiation. Scale bar: 100 μm. [nanomaterials] = 50 μg/mL; [ICG] = 1.68 μM; Laser: 808 nm, 2 W/cm2.

Similar articles

Cited by

References

    1. Chen J., Zhu Y., Wu C., Shi J. Nanoplatform-based cascade engineering for cancer therapy. Chemical Society Reviews . 2020;49(24):9057–9094. doi: 10.1039/D0CS00607F. - DOI - PubMed
    1. Hescham S.-A., Chiang P.-H., Gregurec D., et al. Magnetothermal nanoparticle technology alleviates parkinsonian-like symptoms in mice. Nature Communications . 2021;12(1, article 5569) doi: 10.1038/s41467-021-25837-4. - DOI - PMC - PubMed
    1. Yang J., Yang Y.-W. Metal-organic framework-based cancer theranostic nanoplatforms. View . 2020;1(2):p. e20. doi: 10.1002/viw2.20. - DOI
    1. Zhang P., Wang Y., Lian J., et al. Engineering the surface of smart nanocarriers using a pH-/thermal-/GSH-responsive polymer zipper for precise tumor targeting therapy in vivo. Advanced Materials . 2017;29(36, article 1702311) doi: 10.1002/adma.201702311. - DOI - PubMed
    1. Cheng L., Wang C., Feng L., Yang K., Liu Z. Functional nanomaterials for phototherapies of cancer. Chemical Reviews . 2014;114(21):10869–10939. doi: 10.1021/cr400532z. - DOI - PubMed

LinkOut - more resources